Chlorhexidine
3106-Ped-ERC-14
Approved small_molecule completed
Quick answer
Chlorhexidine for Neonatal Infections is a Approved program (small_molecule) at CRESCENT BIOPHARMA, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CRESCENT BIOPHARMA, INC.
- Indication
- Neonatal Infections
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed